Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited (NATHBIOGEN) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Other Agricultural Products

nathbiogenes.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹153.07
Market cap
291 Cr
Stock P/E
8.2
P/B
0.00
Dividend yield
1.3%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales235 Cr23 Cr32 Cr43 Cr244 Cr32 Cr37 Cr284 Cr44 Cr66 Cr52 Cr328 Cr
Operating expenses (approx.)198 Cr17 Cr26 Cr39 Cr207 Cr27 Cr29 Cr245 Cr38 Cr62 Cr47 Cr293 Cr
EBITDA37 Cr6 Cr6 Cr4 Cr37 Cr5 Cr8 Cr38 Cr6 Cr4 Cr4 Cr35 Cr
OPM %15.6%24.4%17.8%9.1%15.0%15.0%21.8%13.5%13.9%5.4%8.7%10.7%
Other income0.12 Cr0.06 Cr0.04 Cr0.41 Cr0.13 Cr0.08 Cr0.48 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Interest3 Cr2 Cr3 Cr1 Cr2 Cr3 Cr4 Cr3 Cr4 Cr5 Cr5 Cr4 Cr
Depreciation0.76 Cr0.76 Cr0.76 Cr0.98 Cr0.82 Cr0.82 Cr0.82 Cr0.97 Cr0.99 Cr0.98 Cr1 Cr1 Cr
Profit before tax33 Cr2 Cr5 Cr3 Cr34 Cr1 Cr4 Cr38 Cr3 Cr2 Cr2 Cr33 Cr
Tax %0.7%14.3%16.6%19.0%0.7%-2.5%30.1%1.7%18.9%35.2%100.4%2.2%
Net profit33 Cr2 Cr4 Cr3 Cr33 Cr1 Cr3 Cr37 Cr3 Cr2 Cr-0.0092 Cr32 Cr
EPS (₹)₹17.47₹0.86₹2.02₹1.87₹17.49₹0.53₹1.33₹19.58₹1.40₹0.84₹-0.79₹16.98

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales301 Cr333 Cr365 Cr445 CrSign in for TTM
Operating expenses (approx.)253 Cr283 Cr315 Cr393 CrSign in for TTM
EBITDA49 Cr50 Cr50 Cr52 CrSign in for TTM
OPM %16.2%15.0%13.6%11.8%Sign in for TTM
Other income0.55 Cr0.63 Cr5 Cr8 CrSign in for TTM
Interest10 Cr9 Cr10 Cr16 CrSign in for TTM
Depreciation3 Cr3 Cr4 Cr4 CrSign in for TTM
Profit before tax36 Cr42 Cr41 Cr46 CrSign in for TTM
Tax %3.2%4.7%4.9%10.1%Sign in for TTM
Net profit35 Cr40 Cr39 Cr42 CrSign in for TTM
EPS (₹)₹18.42₹21.34₹20.14₹20.98Sign in for TTM
Dividend payout %10.9%-9.6%9.8%9.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital19 Cr19 Cr19 Cr19 Cr
Reserves554 Cr591 Cr625 Cr661 Cr
Borrowings105 Cr105 Cr123 Cr139 Cr
Other liabilities114 Cr165 Cr259 Cr278 Cr
Total liabilities793 Cr880 Cr1,026 Cr1,097 Cr
Fixed assets (net)234 Cr241 Cr243 Cr244 Cr
CWIP0 Cr0 Cr0 Cr0 Cr
Investments5 Cr15 Cr6 Cr6 Cr
Inventories208 Cr230 Cr338 Cr451 Cr
Trade receivables97 Cr94 Cr89 Cr85 Cr
Cash & bank38 Cr77 Cr89 Cr76 Cr
Other assets211 Cr223 Cr261 Cr236 Cr
Total assets793 Cr880 Cr1,026 Cr1,097 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity38 Cr70 Cr18 Cr-13 Cr
Cash from investing-3 Cr-27 Cr-4 Cr3 Cr
Cash from financing-2 Cr-5 Cr-2 Cr-4 Cr
Net cash flow34 Cr38 Cr11 Cr-13 Cr
Free cash flow (OCF − Capex)36 Cr62 Cr10 Cr-16 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %6.8%7.1%6.7%7.6%
ROE %6.1%0.0%0.0%0.0%
Debtor days1181038970
Inventory days645590546536
Days payable86111128156
Cash conversion cycle676583506450
Debt / equity0.180.170.190.20
Current ratio2.412.181.891.97
Net debt / EBITDA1.380.560.671.19

Compare with peers

Loading peers…